Simon Tarsh
Equibles does not estimate personal net worth.
Get an email with a short summary when Lunai Bioworks Inc. publishes a filing, an earnings call transcript or a press release.
Get LNAI alertsAbout Simon Tarsh
Simon Tarsh is recorded as CFO at Lunai Bioworks Inc. (LNAI) since March 11, 2024. Lunai Bioworks Inc. reported in an 8-K filed March 13, 2024 that Simon Tarsh was appointed Interim Chief Financial Officer, effective March 11, 2024. The proxy statement of Lunai Bioworks Inc. reports total compensation of $220,625 for Simon Tarsh in fiscal 2025, including a base salary of $220,625. Disclosed compensation is on record for 2 fiscal years. Lunai Bioworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lunai Bioworks Inc. includes David Weinstein (CEO and Board Member), Eric Leire (CEO), Maurice van Tilburg (CEO) and 7 others.
“The board of directors (the “Board”) of Renovaro Inc. (the “Company”) appointed Simon Tarsh, age 63, as Interim Chief Financial Officer of the Company, effective March 11, 2024.”
Affiliation history
-
Current
2024-03-11–present
Company network
Leadership on record at Lunai Bioworks Inc.
- David Weinstein CEO, Board Member
- Eric Leire CEO
- Maurice van Tilburg CEO
- Robert Wolfe CFO
- Francois Binette PhD COO
- Avram Miller Board Member
- Carol L. Brosgart Board Member
- Gregg Alton Board Member
- James A. McNulty Board Member
- Jayne McNicol Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Lunai Bioworks Inc. (LNAI) | (Chief Financial Officer) | $220,625 | $220,625 |
| 2024 | Lunai Bioworks Inc. (LNAI) | (Chief Financial Officer) | $93,750 | $118,080 |